Download App

Log in to access Online Inquiry
Company Overview More
Oukangwei Biology is a Chinese holding company mainly engaged in the discovery, development and commercialization of ophthalmic therapy. Its main products include OT-401 (YUTIQ), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-301 (NCX 470), OT-101 and OT-202 and so on. The company operates in China.
CEO: Lian Yong CHEN
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

01477 Ocumension Therapeutics-B
11.300+0.040+0.36%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Assets
Current assets
Inventory
64.95% 4.99M 874.26% 2.31M 1068.73% 3.03M -- 237K
Accounts receivable
-8.66% 44.35M 203.44% 71.81M 257.54% 48.56M -- 23.67M
Cash and equivalents
-12.99% 1.79B 202.32% 2.28B 173.39% 2.05B -- 755.28M
Special items of current assets
-- -- -- -- -- -- -- 293.7M
Total current assets
-12.78% 1.83B 119.73% 2.36B 66.67% 2.1B -- 1.07B
Non-current assets
Property, plant and equipment
424.19% 346.41M 2913.52% 143.5M 8383.31% 66.09M -- 4.76M
Advance payment
-30.23% 148.25M 46.36% 160.76M 30739.04% 212.48M -- 109.84M
Intangible assets
252.08% 709.97M 515.68% 354.61M 706.61% 201.65M -- 57.6M
Special items of non-current assets
1730.94% 291.85M 45858.71% 263.8M 1189.64% 15.94M -- 574K
Total non-current assets
201.61% 1.5B 434.04% 922.68M 1690.93% 496.16M -- 172.77M
Total assets
28.14% 3.33B 163.33% 3.28B 101.56% 2.6B -- 1.25B
Liabilities
Current liabilities
Accounts payable
135.19% 211.67M 110.18% 117.68M 135.74% 90M -- 55.99M
Financial lease liabilities-current liabilities
117.23% 4.19M 594.92% 4.11M 53.06% 1.93M -- 591K
Total current liabilities
134.82% 215.85M 115.25% 121.79M 133.11% 91.93M -- 56.58M
Net current assets
-19.53% 1.62B 119.98% 2.24B 64.53% 2.01B -- 1.02B
Total assets less current liabilities
24.23% 3.12B 165.62% 3.16B 100.57% 2.51B -- 1.19B
Non-current liabilities
Financial lease liabilities-non-current liabilities
32.34% 7.03M -- 8.43M -- 5.31M -- --
Special items of non-current liabilities
-- -- -- -- -- -- -- 4.83B
Total non-current liabilities
32.34% 7.03M -99.83% 8.43M -99.84% 5.31M -- 4.83B
Total liabilities
129.22% 222.88M -97.34% 130.22M -97.1% 97.23M -- 4.89B
Total assets less total liabilities
24.21% 3.11B 186.51% 3.15B 220.97% 2.5B -- -3.64B
Total equity and non-current liabilities
24.23% 3.12B 165.62% 3.16B 100.57% 2.51B -- 1.19B
Equity
Share capital
12.2% 46K 633.33% 44K 925% 41K -- 6K
Reserve
24.21% 3.11B 186.5% 3.15B 220.97% 2.5B -- -3.64B
Legal reserve
24.21% 3.11B 186.5% 3.15B 220.97% 2.5B -- -3.64B
Shareholders' Equity
24.21% 3.11B 186.51% 3.15B 220.97% 2.5B -- -3.64B
Total equity
24.21% 3.11B 186.51% 3.15B 220.97% 2.5B -- -3.64B
Total equity and total liabilities
28.14% 3.33B 163.33% 3.28B 101.56% 2.6B -- 1.25B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
IASIASIASIAS
Audit Opinions
Unqualified Opinion--Unqualified Opinion--
Auditor
Deloitte Guan Huang Chen Fang Accountants--Deloitte Guan Huang Chen Fang Accountants--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%